Epinephrine Injection
Product Images NDC 85766-303

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 85766-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epinephrine Structrual Formula (Image 01)

Chemical structure of epinephrine, depicting its molecular arrangement with a benzene ring substituted with hydroxyl groups and an amine side chain.*

FDA Label Image

Figure A (Image 02)

Illustration showing two Epinephrine Injection, USP Auto-Injectors for intramuscular use available in 0.3 mg and 0.15 mg strengths. Each auto-injector features a blue safety top, medicine viewing window, protective case, needle end, and color-coded caps and labels—yellow for 0.3 mg and green for 0.15 mg.*

FDA Label Image

Figure B (Image 03)

An illustration showing the location of intramuscular injection sites on the outer thigh for administration. The image includes a pair of pants with two green highlighted areas labeled as injection sites on each thigh, suitable for epinephrine injection.*

FDA Label Image

Figure C (Image 04)

An instructional illustration shows a hand gripping an epinephrine injection pen, positioned vertically with the needle end pointing downward inside a green circular border. This image likely represents how to hold the epinephrine intramuscular injection device for administration.*

FDA Label Image

Figure D And Figure E (Image 05)

An instructional diagram illustrating the proper use of an Epinephrine injection auto-injector. The left image (with a green border) shows a blue safety top that is not raised, indicating the auto-injector is okay to use. The right image (with a red border) shows a blue safety top that is raised, indicating the auto-injector should not be used and must be replaced.*

FDA Label Image

Figure F (Image 06)

The image shows a training injector device labeled 'Epinephrine Trainer For Practice Only,' designed to simulate epinephrine injection without containing the actual drug. It is an intramuscular injection trainer, branded for practice use, with clear instructions on how to use the trainer. The device is cylindrical with an orange tip and blue end, intended for user training rather than patient administration. The labeler is Sportpharm LLC.*

FDA Label Image

Figure G (Image 07)

An instructional diagram showing two representations of an intramuscular injection device labeled 'Epinephrine.' The top image illustrates the device with the needle hidden before use, and the bottom image shows the device after use with the needle exposed. Labels point to the needle in both states indicating 'Hidden needle before use' and 'Hidden needle after use.'*

FDA Label Image

Figure H (Image 08)

Epinephrine injection pen label showing the 0.15 mg/0.3 mL strength for intramuscular use. The label includes dosage instructions and a depiction of the pen device. The labeler is Sportpharm LLC. Packaging highlights the epinephrine auto-injector functionality for emergency use.*

FDA Label Image

Figure I (Image 09)

An instructional illustration showing a person preparing an epinephrine injection auto-injector. One hand holds the device while the other hand is positioned to activate or remove a cap. The injection pen is yellow with a prominent button or activation area, typical for intramuscular epinephrine administration.*

FDA Label Image

Figure J (Image 10)

An instructional illustration showing how to prepare an intramuscular epinephrine injection by pulling off the blue safety top from the device. The needle end with an orange tip is visible at the bottom, with arrows and labels indicating the steps to remove the safety cover.*

FDA Label Image

Figure K (Image 11)

An instructional illustration showing how to administer an intramuscular injection in the thigh. It instructs to push the device hard against the leg until a 'pop' is heard, then hold it for 1 to 2 to 3 seconds for proper delivery.*

FDA Label Image

Figure L (Image 12)

An instructional illustration showing how to administer an intramuscular injection of Epinephrine by pushing hard against the outer thigh. The steps emphasize holding the injector in place for 1 to 3 seconds after hearing a 'pop' sound, with a visual of a person pressing the device against the leg.*

FDA Label Image

Figure M (Image 13)

An instructional diagram showing a hand holding a syringe for intramuscular injection at the outer thigh, with an arrow indicating the direction to administer the injection into the leg muscle.*

FDA Label Image

Figure A (Image 14)

Illustration showing the gray trainer device for Epinephrine injection practice, labeled with a blue safety top on the left and an orange end on the right. The diagram highlights parts of the trainer, indicating it is for practice only.*

FDA Label Image

Important Differences (Image 22)

Labels of Epinephrine Injection, USP Auto-Injector showing two dose strengths: 0.3 mg with an orange end cap and 0.15 mg with a green end cap. The image includes the auto-injectors both in and removed from their carrier tubes, as well as a blue-capped trainer device labeled for practice only. The product is for intramuscular injection and labeled by Sportpharm LLC.*

FDA Label Image

Figure B (Image 15)

An instructional illustration showing how to remove the blue safety top from an Epinephrine injection device by pulling it off upward. The image also indicates the orange end of the device, suggesting the correct orientation for intramuscular administration.*

FDA Label Image

Figure C (Image 16)

An instructional illustration demonstrating the correct intramuscular injection technique for Epinephrine. The diagram shows a person injecting the medication into the outer thigh with instructions to push hard against the leg until a "pop" sound is heard, then hold for 1-2-3 seconds after the pop.*

FDA Label Image

Figure D (Image 17)

An instructional illustration showing the proper administration of epinephrine injection intramuscularly. The image depicts a person pushing the injection hard against their leg with a ‘pop’ sound, followed by a directive to hold the injection in place for 1 to 3 seconds.*

FDA Label Image

Figure E (Image 18)

An illustration showing a syringe with an orange end extending, accompanied by the instruction to check if the orange end has extended, indicating usage status.*

FDA Label Image

Figure F (Image 19)

An instructional illustration showing a hand holding an epinephrine autoinjector with arrows indicating a downward pressing motion to activate the device against a surface, illustrating proper injection technique.*

FDA Label Image

Label (Image 20)

Packaging label for Sportpharm Epinephrine Injection USP Single-Dose Auto-Injector 0.3 mg, manufactured by Mylan Specialty L.P. The label indicates a package quantity of 2 auto-injectors and includes NDC 85766-304-02, batch number, expiration date, and storage instructions. The label features a Sportpharm logo and regulatory information.*

FDA Label Image

Label (Image 21)

Packaging label for Epinephrine Injection USP Single-Dose Auto-Injector 0.15 mg by Sportpharm LLC. The label indicates a quantity of 2 auto-injectors, with manufacturing by Mylan Specialty L.P. It includes NDC 85766-303-02 and storage instructions, along with a barcode and QR code on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.